BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2264 related articles for article (PubMed ID: 26971743)

  • 21. Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenström's macroglobulinemia: case report and review of the literature.
    Yahata M; Nakaya I; Takahashi S; Sakuma T; Sato H; Soma J
    Clin Nephrol; 2012 Mar; 77(3):254-60. PubMed ID: 22377259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo C3 glomerulonephritis in a renal allograft.
    Nahm JH; Song SH; Kim YS; Cheong HI; Lim BJ; Kim BS; Jeong HJ
    Ultrastruct Pathol; 2016; 40(2):112-5. PubMed ID: 26986539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classification.
    Unagami K; Kawanishi K; Shimizu T; Kanzawa T; Toki D; Okumi M; Omoto K; Horita S; Koike J; Honda K; Nagashima Y; Ishida H; Tanabe K; Nitta K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():96-100. PubMed ID: 26031598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rapidly progressive proliferative glomerulonephritis with monoclonal immunoglobulin G deposits despite the mild histological changes. Case report].
    Bajcsi D; Constantinou K; Krenács L; Barabás Z; Molnár S; Nyiraty S; Ábrahám G; Iványi B
    Orv Hetil; 2018 Sep; 159(38):1567-1572. PubMed ID: 30227733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature.
    Oki R; Unagami K; Taneda S; Takagi T; Ishida H
    J Nephrol; 2022 May; 35(4):1289-1293. PubMed ID: 35522429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
    Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin A Deposits In Renal Allografts: A Prospective Longitudinal Single-Center Study.
    Ganesh K; Jayaram JK; Thomas RM; Abraham TT; Kumar JS; Simon SS; Abraham MA
    Transplant Proc; 2024; 56(1):97-104. PubMed ID: 38216361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M; Suzuki H; Kato R; Fukao Y; Nakayama M; Kano T; Makita Y; Suzuki Y
    CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of proliferative glomerulonephritis with monoclonal IgG deposits in pediatric patients.
    Miller P; Xiao AY; Kung VL; Sibley RK; Higgins JP; Kambham N; Charu V; Lenihan C; Uber AM; Talley EM; Arora N; Walavalkar V; Laszik ZG; Nast CC; Troxell ML
    Pediatr Nephrol; 2021 Apr; 36(4):927-937. PubMed ID: 33044675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy.
    Wada Y; Ogata H; Takeshige Y; Takeshima A; Yoshida N; Yamamoto M; Ito H; Kinugasa E
    Clin Exp Nephrol; 2013 Feb; 17(1):73-82. PubMed ID: 22752397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit.
    Maity P; Dasgupta S; Basu K; Sengupta M; Chowdhury AR; Bandopadhyay M
    Indian J Pathol Microbiol; 2021; 64(2):282-287. PubMed ID: 33851621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.
    Yan Y; Xu LX; Zhang JJ; Zhang Y; Zhao MH
    Clin Exp Immunol; 2006 Apr; 144(1):17-24. PubMed ID: 16542360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
    Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
    BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin G deposits leads to rapid graft loss after kidney transplantation: a case report.
    Kawanishi K; Honda K; Horita S; Koike J; Shimizu T; Tanabe K; Yamaguchi Y; Nitta K
    CEN Case Rep; 2014 Nov; 3(2):139-144. PubMed ID: 28509187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myeloma.
    Herrmann SM; Govani MV; Fidler ME; Nasr SH; Klink D; Amin C; Leung N; Fervenza FC
    Clin Nephrol; 2015 Oct; 84(4):241-6. PubMed ID: 25373138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent proliferative glomerulonephritis with monoclonal IgG deposits of IgG2λ subtype in a transplanted kidney: a case report.
    Sumida K; Ubara Y; Marui Y; Nakamura M; Takaichi K; Tomikawa S; Fujii T; Ohashi K
    Am J Kidney Dis; 2013 Sep; 62(3):587-90. PubMed ID: 23474011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits.
    Zhang F; Gao E; Liang S; Yang N; Wang J
    Ann Clin Lab Sci; 2018 Jul; 48(4):528-533. PubMed ID: 30143498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of recurrent Henoch-Schönlein purpura nephritis in a renal allograft with tonsillectomy and steroid pulse therapy.
    Yamakawa T; Yamamoto I; Komatsuzaki Y; Niikura T; Okabayashi Y; Katsumata H; Kawabe M; Katsuma A; Mafune A; Nakada Y; Kobayashi A; Koike Y; Miki J; Yamada H; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():53-6. PubMed ID: 26973131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological study of de novo membranous nephropathy of 'stage 0' after kidney transplantation.
    Katsuma A; Nakada Y; Yamamoto I; Horita S; Katsumata H; Kobayashi A; Unagami K; Okumi M; Ishida H; Yokoo T; Yamaguchi Y; Tanabe K;
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():63-69. PubMed ID: 29968407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 114.